Respiratory Oscillometry and Functional Performance in Different COPD Phenotypes

Int J Chron Obstruct Pulmon Dis. 2024 Mar 6:19:667-682. doi: 10.2147/COPD.S446085. eCollection 2024.

Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) phenotypes may introduce different characteristics that need to be known to improve treatment. Respiratory oscillometry provides a detailed analysis and may offer insight into the pathophysiology of COPD. In this paper, we used this method to evaluate the differences in respiratory mechanics of COPD phenotypes.

Patients and methods: This study investigated a sample of 83 volunteers, being divided into control group (CG = 20), emphysema (n = 23), CB (n = 20) and asthma-COPD overlap syndrome (ACOS, n = 20). These analyses were performed before and after bronchodilator (BD) use. Functional capacity was evaluated using the Glittre‑ADL test, handgrip strength and respiratory pressures.

Results: Initially it was observed that oscillometry provided a detailed description of the COPD phenotypes, which was consistent with the involved pathophysiology. A correlation between oscillometry and functional capacity was observed (r=-0.541; p = 0.0001), particularly in the emphysema phenotype (r = -0.496, p = 0.031). BD response was different among the studied phenotypes. This resulted in an accurate discrimination of ACOS from CB [area under the receiver operating curve (AUC) = 0.84] and emphysema (AUC = 0.82).

Conclusion: These results offer evidence that oscillatory indices may enhance the comprehension and identification of COPD phenotypes, thereby potentially improving the support provided to these patients.

Keywords: Glittre-ADL test; asthma-COPD overlap; bronchodilator response; chronic bronchitis; emphysema; forced oscillation technique; handgrip analysis; respiratory impedance.

MeSH terms

  • Asthma*
  • Bronchodilator Agents / therapeutic use
  • Emphysema*
  • Forced Expiratory Volume
  • Hand Strength
  • Humans
  • Lung
  • Oscillometry / methods
  • Phenotype
  • Physical Functional Performance
  • Pulmonary Disease, Chronic Obstructive* / diagnosis
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Pulmonary Emphysema*

Substances

  • Bronchodilator Agents